Study to Evaluate the Effects of Cenicriviroc Mesylate on Arterial Inflammation in People Living With HIV

Stopped Industry supporter no longer supporting the study. Protocol A5415's study will run instead.

Conditions

• HIV Infections

Interventions

• DRUG: Cenicriviroc Mesylate (CVC)
• DRUG: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

• [object Object]